H&Q Asia Pacific

years experience in cross-border strategy in Asia Billion in assets under management H&Q Asia Pacific is a leading technology venture investment firm in Silicon Valley and also a cross-border venture pioneer in Asia with over 34 years’ track record Originally founded by Dr Ta-lin Hsu as a division of U S investment banking firm Hambrecht & Quist, H&QAP was the first US-style venture capital firm in Asia and has managed an aggregate of US dollar 3 4 billion in committed capital across 29 funds and over 400 invested companies since its inception in 1985 H&QAP has continued its investment focus on early stage investments in both US and Asia, with the attribute of having strong cross-border potential primarily between Asia and the US, with considerations to other countries such as Israel H&QAP is dedicated to identifying superior commercial opportunities in both US and Asia and working closely with companies to unlock their untapped potential to take advantage of large market on both side of pacific ocean Throughout its long history, H&QAP has nurtured an extensive local and global network through its portfolio companies and industry relationships, creating a fulcrum to helping future portfolio companies emerge into global business leaders

PhiSkin is a holding company which will be mainly engaged in managing a network of outpatient centers and clinics to provide dermatology disease treatment and medical esthetic services under the “PhiSkin” brand

A Taiwan-based clinical-stage biotechnology company, principally engaged in the research and development of anti-cancer new drugs and special drug substances

Cummins Announces Acquisition of Electric and Hybrid Powertrain Provider

COLUMBUS, Ind --(BUSINESS WIRE)--Cummins Inc (NYSE: CMI) today announced that it is acquiring Silic